InvestorsHub Logo
Followers 135
Posts 13914
Boards Moderated 0
Alias Born 09/05/2013

Re: MWM post# 420

Friday, 04/17/2020 3:07:03 PM

Friday, April 17, 2020 3:07:03 PM

Post# of 484
Eh? The virus is SARS-2, not Covid19. You can't patent a respiratory syndrome, but you can patent a virus. The money and power gained from all of this will be just as much from the cure as the disease. Problem, reaction, solution works best when you have the solution ready in advance...

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7075527/

But, for shits and giggles, let's look at who came to own the patent on SARS-1 after it's 2003 breakout in China, so maybe we can have some idea of who may come to own SARS-2:

https://pubchem.ncbi.nlm.nih.gov/patent/US2006257852#section=Patent-Identifier-Synonyms

SARS-1 is owned by CHIRON CORP. Chiron Corp's VP of Vaccines left Chiron and went to Bill's Foundation:

Margaret Ann Liu

Meanwhile I was settling into my role as Vice-President of Vaccines at Chiron, a biotech company. This was soon expanded to Vice-President of Vaccines and Gene Therapy as I gained responsibility for the gene therapy efforts that Chiron assumed by its purchase of the company Viagene. At Chiron our projects included HIV and HCV vaccines and various related technologies (DNA vaccines, adjuvants, replicons), as well as gene therapy, notably for hemophilia A. Then priorities changed with a new CEO, and Chiron decided to focus more on combichem (and not gene therapy); I left, leaving behind a strengthened vaccine group in the US.
The Bill & Melinda Gates Foundation asked me to become their Senior Advisor in Vaccinology.


https://www.tandfonline.com/doi/full/10.1080/21645515.2019.1597583

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.